Selective Kinase Inhibition by Exploiting Differential Pathway Sensitivity
- 30 April 2006
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 13 (4) , 399-407
- https://doi.org/10.1016/j.chembiol.2006.02.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- PEGylation, successful approach to drug deliveryDrug Discovery Today, 2005
- Graded Mitogen-Activated Protein Kinase Activity Precedes Switch-Like c-Fos Induction in Mammalian CellsMolecular and Cellular Biology, 2005
- Structural Bioinformatics-Based Design of Selective, Irreversible Kinase InhibitorsScience, 2005
- Design, Synthesis, and Analysis of a Polyethelene Glycol-Modified (PEGylated) Small Molecule Inhibitor of Integrin α4β1 with Improved Pharmaceutical PropertiesThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Exploring biology with small organic moleculesNature, 2004
- Partially Phosphorylated Pho4 Activates Transcription of a Subset of Phosphate-Responsive GenesPLoS Biology, 2003
- Targets of the cyclin-dependent kinase Cdk1Nature, 2003
- Inhibitor Scaffolds as New Allele Specific Kinase SubstratesJournal of the American Chemical Society, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replicationNature, 2001